| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-8 |
SP_7 |
denotes |
COVID-19 |
| T2 |
164-175 |
UBERON:0001004 |
denotes |
respiratory |
| T3 |
176-187 |
NCBITaxon:11118 |
denotes |
coronavirus |
| T4 |
200-210 |
SP_7 |
denotes |
SARS-CoV-2 |
| T5 |
288-294 |
GO:0016265 |
denotes |
deaths |
| T6 |
454-464 |
SP_7 |
denotes |
SARS-CoV-2 |
| T7 |
505-512 |
SO:0000704 |
denotes |
genetic |
| T8 |
547-555 |
SP_10 |
denotes |
SARS-CoV |
| T9 |
625-630 |
CHEBI:23888;CHEBI:23888 |
denotes |
drugs |
| T10 |
802-810 |
SP_10 |
denotes |
SARS-CoV |
| T11 |
827-838 |
NCBITaxon:11118 |
denotes |
coronavirus |
| T12 |
839-850 |
UBERON:0001004 |
denotes |
respiratory |
| T13 |
897-915 |
CHEBI:5801;DG_20;CHEBI:5801 |
denotes |
hydroxychloroquine |
| T14 |
917-927 |
DG_28 |
denotes |
remdesivir |
| T15 |
929-940 |
CHEBI:119915;DG_17;CHEBI:119915;NCBITaxon:31032 |
denotes |
favipiravir |
| T16 |
942-949 |
CHEBI:57472;DG_49;CHEBI:57472 |
denotes |
arbidol |
| T17 |
951-962 |
DG_35 |
denotes |
tocilizumab |
